Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-05 4:17 pm |
N/A 2035-02-03 |
MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 5:13 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer |
42,578 | $0 | 42,578 (Direct) |
View |
Ownership |
2024-09-12 7:09 pm |
N/A 2032-04-19 |
MBX Biosciences Inc. | MBX | Bartram Richard Chief Financial Officer |
0 | $0 | 225,592 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 5:09 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
37,000 | $0 | 241,751 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
18,700 | $0 | 70,352 (Direct) |
View |
| 2021-06-28 Option Award |
2021-06-30 4:27 pm |
N/A 2031-06-28 |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
63,900 | $0 | 63,900 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:01 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
55,000 | $0 | 73,617 (Direct) |
View |